Intrinsic Value

Stock has not been able to generate better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Take Solutions reports consolidated net loss of Rs 728.35 crore in the March 2022 quarter

Take Solutions Ltd, Banaras Beads Ltd, Vishal Fabrics Ltd and Sterling Tools Ltd are among the other losers in the BSE’s ‘B’ group today, 14 March 2022.

One 97 Communications Ltd leads losers in ‘B’ group

Optiemus Infracom Ltd, KCP Sugar & Industries Corporation Ltd, TTK Healthcare Ltd and Orient Press Ltd are among the other gainers in the BSE’s ‘B’ group today, 09 March 2022.

Take Solutions Ltd leads gainers in ‘B’ group

Take Solutions reports consolidated net loss of Rs 41.82 crore in the December 2021 quarter

The discontinuation of the proposed stake sale will compel the company to be in default of its debt obligations.

TAKE Solutions to abort proposed stake sale of CRO business; Stock surges 4.5%

The primary purpose of this transaction was to deleverage of the company; and to comply with its current debt obligations. The discontinuation of the proposed stake sale will compel the company to be in default of its debt obligations.

Take Solutions aborts proposed stake sale of its CRO business

Healthcare Veteran, Dhamu Narayanan to pilot the technology business (non CRO business) at TAKE Solutions.

TAKE Solutions appoints Dhamu Narayanan as Chief Operating Officer

An innovative Regulatory Technology, pharmaREADY drives accelerated compliance and delivering first‐time‐right submissions.

Take Solutions led Navitas Life Sciences’ achieves 200 active customers for pharmaREADY; Stock jumps 3%

Take Solutions reports consolidated net loss of Rs 3.19 crore in the June 2021 quarter

Miami-based H.I.G. Capital, a leading global alternative investment firm, as a strategic partner will be acquiring 75% stake in Navitas Life Science, the wholly owned subsidiary of TAKE Solutions, by

H.I.G. Capital to acquire 75% stake in TAKE Solutions’ arm

H.I.G. to support Navitas Life Sciences’ and its continued growth as a Global Next Generation CRO.

TAKE Solutions forms strategic partnership with H I G Capital; Stock zooms 7.5%

TAKE Solutions Limited is engaged in computer programming, consultancy and related activities. It provides a range of domain knowledge and technology-based solutions primarily across two business verticals, Life Sciences and Supply Chain Management.

Take Solutions Ltd

Take Solutions Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Take Solutions reports consolidated net loss of Rs 728.35 crore in the March 2022 quarter

One 97 Communications Ltd leads losers in ‘B’ group

Take Solutions Ltd leads gainers in ‘B’ group

Take Solutions reports consolidated net loss of Rs 41.82 crore in the December 2021 quarter

TAKE Solutions to abort proposed stake sale of CRO business; Stock surges 4.5%

Take Solutions aborts proposed stake sale of its CRO business

TAKE Solutions appoints Dhamu Narayanan as Chief Operating Officer

Take Solutions Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Take Solutions reports consolidated net loss of Rs 728.35 crore in the March 2022 quarter

One 97 Communications Ltd leads losers in ‘B’ group

Take Solutions Ltd leads gainers in ‘B’ group

Take Solutions reports consolidated net loss of Rs 41.82 crore in the December 2021 quarter

TAKE Solutions to abort proposed stake sale of CRO business; Stock surges 4.5%

Take Solutions aborts proposed stake sale of its CRO business

TAKE Solutions appoints Dhamu Narayanan as Chief Operating Officer

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock